Telomere Dynamics in Myelodysplastic Syndromes and Acute Leukemic Transformation

References

• Ohyashiki K., Ohyashiki J. H., Iwabuchi A., Toyama K. Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes. Leuk. Lymphoma 1996; 23: 409–415
   PubMed Web of Science ®Google Scholar
• Toyama K., Ohyashiki K., Yoshida Y., et al. Clinical implcations of chromosomal abnormalities in 401 patients with MDS: A multicentric study in Japan. Leukemia 1993; 7: 499–508
   PubMed Web of Science ®Google Scholar
• Morel P., Hebbar M., Lai J. L., et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315–1323
   PubMed Web of Science ®Google Scholar
• Greenberg P., Cox C., Le Beau M. M., et al. International scoring system for evaluating prognosis in Myelodysplastic syndrome. Blood 1997; 89: 2079–2088
   PubMed Web of Science ®Google Scholar
• Harley C. B., Futcher A. B., Greider C W. Telomeres shortening during aging of human fibroblasts. Nature (London) 1990; 345: 458–460
   PubMed Web of Science ®Google Scholar
• Allsopp R. C., Vaziri H., Patterson C., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S.A. 1992; 89: 10114–10118
   PubMed Web of Science ®Google Scholar
• Moyzis R. K., Buckingham J. M., Cram L. S., et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA. 1988; 85: 6622–6626
   PubMed Web of Science ®Google Scholar
• Shay J. W., Wright W E. Telomerase activity in human cancer. Current Opinion Oncol. 1996; 8: 66–71
   PubMedGoogle Scholar
• Bacchetti S., Counter C M. Telomeres and telomerase in human cancer (review). Int. J. Oncol. 1995; 7: 423–432
   PubMed Web of Science ®Google Scholar
• Hiyama E., Hiyama K, Yokoyama T., Matsuura Y., Piatyszek M. A., Shay J W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med 1995; 1: 249–255
   PubMed Web of Science ®Google Scholar
• Hiyama E., Ichikawa T., Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn. J Cancer Res. 1992; 83: 159–64
   PubMedGoogle Scholar
• Bennett J. M., Catovsky D., Daniel M. T., et al. Proposal for the classification of the myelodysplastic syndrome. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Deeg H J., Beckham C., Loken M. R., et al. Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome. Leuk. Lymphoma 2000; 37: 405–414
   PubMed Web of Science ®Google Scholar
• Reza S., Cartlidge J. D., et al. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows. Int. J. Hematol. 1999; 70: 83–90
   PubMed Web of Science ®Google Scholar
• Yoshida Y., Mufti G J. Apoptosis and its significance in MDS: controversies revisited. Leuk. Res. 1999; 23: 777–785
   PubMed Web of Science ®Google Scholar
• Counter C. M., Avilion A. A., LeFeuvre C. E., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992; 11: 1921–1929
   PubMed Web of Science ®Google Scholar
• Li B., Yang J., Andrews C., et al. Telomerase activity in preleukemia and acute myelogenous leukemia. Leuk. Lymphoma 2000; 36: 579–587
   PubMed Web of Science ®Google Scholar
• Ohyashiki J. H., Iwama H., Yahata N., et al. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clin. Cancer Res. 1999; 5: 1155–1160
   PubMed Web of Science ®Google Scholar
• Counter C. M., Gupta J., Harley C. B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315–2320
   PubMed Web of Science ®Google Scholar
• Ohyashiki J. H., Ohyashiki K., Aizawa S., et al. Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia. Clin. Cancer Res. 1996; 2: 1583–1589
   PubMed Web of Science ®Google Scholar
• Iwama H., Ohyashiki K., Ohyashiki J. H., et al. Telomere length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Human Genet. 1998; 102: 397–402
   PubMed Web of Science ®Google Scholar
• Kaneko H., Horiike S., Taniwaki M., Misawa S. Microsatellite instability is an early genetic event in myelodysplastic syndrome but is infrequent and not associated with TGF-beta receptor type n gene mutation. Leukemia 1996; 10: 1696–1699
   PubMed Web of Science ®Google Scholar
• Boyer J. C., Risinger J. I., Farber R A. Stability of microsatellites in myeloid neoplasias. Cancer Genet. Cytogenet. 1998; 106: 54–61
   PubMed Web of Science ®Google Scholar
• Sill H., Goldman J. M., Cross N C. Rarity of microsatellite alterations in acute myeloid leukaemia. Br. J. Cancer 1996; 74: 255–257
   PubMed Web of Science ®Google Scholar
• Tasaka T., Lee S., Spira S., et al. Microsatellite instability during the progression of acute myelocytic leukaemia. Br. J. Haematol. 1997; 98: 219–221
   PubMed Web of Science ®Google Scholar
• Boultwood J., Fidler C., Kusec R., et al. Telomere length in myelodysplastic syndromes. Am. J. Hematol. 1997; 56: 266–271
   PubMed Web of Science ®Google Scholar
• Iwama H., Ohyashiki K., Ohyashiki J H, Hayashi S., Shay J. W., Toyama K. The relationship between telomere length and therapy-associated cytogenetic responses in chronic myeloid leukemia. Cancer 1997; 79: 1552–1560
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Ohyashiki J. H., Iwama H., Hayashi S., Shay J. W., Toyama K. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 1997; 11: 190–195
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Iwama H., Tauchi T., et al. Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia: Based on our experience. Leuk, Lymphoma. 2000
   Web of Science ®Google Scholar
• Ohyashiki J. H., Ohyashiki K., Fujimura T., et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res. 1994; 54: 3557–3360
   PubMed Web of Science ®Google Scholar
• Bryan T. M., Englezou A., Dalla-Pozza L., Dunham M. A., Reddel R R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Medicine 1997; 3: 1271–1274
   PubMed Web of Science ®Google Scholar
• Bryan T. M., Marusic L., Bacchett S., Namba M., Reddel R R. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 1997; 6: 921–926
   PubMed Web of Science ®Google Scholar